FOXK2 and neoplasm: FT282-C11 cells have low expression of FOXM1, FOXM1-P (activated FOXM1), CCNB1 (canonical FOXM1 target), FOXA1, and FOXK2 (all oncoproteins), and elevated FOXO3a (a tumor suppressor), as compared to HGSOC cells (Fig. 1A), validating their utility as a normal control.